BTIG Upgrades 1Life Healthcare to Buy, Announces $15 Price Target

BTIG analyst David Larsen upgrades 1Life Healthcare (NASDAQ:ONEM) from Neutral to Buy and announces $15 price target.

BTIG analyst David Larsen upgrades 1Life Healthcare (NASDAQ:ONEM) from Neutral to Buy and announces $15 price target.

Total
0
Shares
Related Posts
Read More

Another Cannabis Pioneer Expands In Germany Via Acquisition As Experts Say ‘There’s No Stepping Back’ From Legalization Wave

Flora Growth Corp. has entered into a definitive agreement to acquire all of the issued and outstanding shares of Hamburg, Germany-based TruHC Pharma GmbH. The company's latest move to further cement its global footprint comes on the heels of a new German cannabis law that went into effect on April 1, which partially legalized cannabis. The new law allows adults over 18 in Germany to legally possess up to 25 grams of dried cannabis and cultivate up to three marijuana plants at home.As previously announced, Flora agreed to purchase TruHC Pharma GmbH in an all-stock deal in exchange for 2,770,562 of its common shares, valued at $6.4 million.

ACB